Clinical Trial

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Study acronym: PAAD
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
Patients with pancreatic adenocarcinoma are frequently in a situation of malnutrition, in a context of functional alteration of the digestive tract, and hypercatabolism. As a result, nutritional support is frequently necessary perioperatively, but currently does not follow a specific protocol, and without coordination. It then appears the need to evaluate the prevalence of malnutrition, its impact on perioperative morbidity and mortality, and current management methods. Depending on the findings, subsequent interventional studies will be carried out on the subject, exploring the different modalities of artificial nutrition.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06893536
Lead Sponsor University Hospital, Strasbourg, France
Conditions Pancreatic Adenocarcinoma
Enrollment 100 participants
Start Date 2023-10-12
Primary Completion 2025-10 (estimated)
Study Completion 2025-10-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-25